Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Maier to Beryllium

This is a "connection" page, showing publications Lisa Maier has written about Beryllium.

 
Connection Strength
 
 
 
10.652
 
  1. Crooks J, Mroz MM, VanDyke M, McGrath A, Schuler C, McCanlies EC, Virji MA, Rosenman KD, Rossman M, Rice C, Monos D, Fingerlin TE, Maier LA. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease. Occup Environ Med. 2022 02; 79(2):120-126.
    View in: PubMed
    Score: 0.802
  2. MacMurdo MG, Mroz MM, Culver DA, Dweik RA, Maier LA. Chronic Beryllium Disease: Update on a Moving Target. Chest. 2020 12; 158(6):2458-2466.
    View in: PubMed
    Score: 0.742
  3. Li L, Silveira LJ, Hamzeh N, Gillespie M, Mroz PM, Mayer AS, Fingerlin TE, Maier LA. Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis. Eur Respir J. 2016 06; 47(6):1797-808.
    View in: PubMed
    Score: 0.551
  4. Li L, Hamzeh N, Gillespie M, Elliott J, Wang J, Gottschall EB, Mroz PM, Maier LA. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease. PLoS One. 2015; 10(2):e0117276.
    View in: PubMed
    Score: 0.508
  5. Li L, Huang Z, Gillespie M, Mroz PM, Maier LA. p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation. Hum Immunol. 2014 Dec; 75(12):1155-62.
    View in: PubMed
    Score: 0.497
  6. Mayer AS, Hamzeh N, Maier LA. Sarcoidosis and chronic beryllium disease: similarities and differences. Semin Respir Crit Care Med. 2014 Jun; 35(3):316-29.
    View in: PubMed
    Score: 0.487
  7. Fireman E, Lerman Y, Stark M, Pardo A, Schwarz Y, Van Dyke MV, Elliot J, Barkes B, Newman L, Maier L. A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects. J Occup Environ Hyg. 2014; 11(12):809-18.
    View in: PubMed
    Score: 0.470
  8. Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove. J Immunol. 2012 Oct 15; 189(8):4014-23.
    View in: PubMed
    Score: 0.429
  9. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Cragle DL, Tankersley WG, Wells SM, Newman LS, Maier LA. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. Occup Environ Med. 2011 Nov; 68(11):842-8.
    View in: PubMed
    Score: 0.388
  10. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1680-8.
    View in: PubMed
    Score: 0.387
  11. Middleton DC, Mayer AS, Lewin MD, Mroz MM, Maier LA. Interpreting borderline BeLPT results. Am J Ind Med. 2011 Mar; 54(3):205-9.
    View in: PubMed
    Score: 0.376
  12. Maier LA, Martyny JW, Liang J, Rossman MD. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med. 2008 May 01; 177(9):1012-7.
    View in: PubMed
    Score: 0.312
  13. Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, Lagan AL, Lympany P, Sawyer RT, du Bois RM, Welsh KI, Maier LA. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol. 2007 Mar; 119(3):687-96.
    View in: PubMed
    Score: 0.290
  14. Fontenot AP, Maier LA. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Trends Immunol. 2005 Oct; 26(10):543-9.
    View in: PubMed
    Score: 0.265
  15. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005 Jan 01; 171(1):54-60.
    View in: PubMed
    Score: 0.247
  16. Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003 Dec 15; 171(12):6910-8.
    View in: PubMed
    Score: 0.234
  17. Maier LA, Kittle LA, Mroz MM, Newman LS. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. Am J Ind Med. 2003 Jun; 43(6):592-601.
    View in: PubMed
    Score: 0.226
  18. Adduri RSR, Vasireddy R, Mroz MM, Bhakta A, Li Y, Chen Z, Miller JW, Velasco-Alzate KY, Gopalakrishnan V, Maier LA, Li L, Konduru NV. Realistic biomarkers from plasma extracellular vesicles for detection of beryllium exposure. Int Arch Occup Environ Health. 2022 10; 95(8):1785-1796.
    View in: PubMed
    Score: 0.210
  19. Maier L, Martyny J, Mroz M, McGrath D, Lympany P, duBois R, Zhang L, Murphy J, Newman LS. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease. Chest. 2002 Mar; 121(3 Suppl):81S.
    View in: PubMed
    Score: 0.207
  20. Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff E, Rose CS, Newman LS. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med. 2001 Oct 01; 164(7):1192-9.
    View in: PubMed
    Score: 0.201
  21. Falta MT, Crawford JC, Tinega AN, Landry LG, Crawford F, Mack DG, Martin AK, Atif SM, Li L, Santos RG, Nakayama M, Kappler JW, Maier LA, Thomas PG, Pinilla C, Fontenot AP. Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation. J Clin Invest. 2021 05 03; 131(9).
    View in: PubMed
    Score: 0.195
  22. Maier LA. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg. 2001 May; 16(5):514-20.
    View in: PubMed
    Score: 0.195
  23. Smith DE, Golden AP, Stange AW, Barker E, Mroz M, BarĂ³n AE, Ghosh D, Maier L, Cragle D, Newman LS. Clinical and laboratory factors contributing to uninterpretable beryllium lymphocyte proliferation tests (BeLPT). Am J Ind Med. 2018 07; 61(7):592-604.
    View in: PubMed
    Score: 0.157
  24. Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, Muller-Quernheim J, Ostiguy G, Pepper LD, Saltini C, Schuler CR, Takaro TK, Wambach PF. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014 Nov 15; 190(10):e34-59.
    View in: PubMed
    Score: 0.125
  25. Stark M, Lerman Y, Kapel A, Pardo A, Schwarz Y, Newman L, Maier L, Fireman E. Biological exposure metrics of beryllium-exposed dental technicians. Arch Environ Occup Health. 2014; 69(2):89-99.
    View in: PubMed
    Score: 0.117
  26. Falta MT, Pinilla C, Mack DG, Tinega AN, Crawford F, Giulianotti M, Santos R, Clayton GM, Wang Y, Zhang X, Maier LA, Marrack P, Kappler JW, Fontenot AP. Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. J Exp Med. 2013 Jul 01; 210(7):1403-18.
    View in: PubMed
    Score: 0.113
  27. Fireman E, Shai AB, Lerman Y, Topilsky M, Blanc PD, Maier L, Li L, Chandra S, Abraham JM, Fomin I, Aviram G, Abraham JL. Chest wall shrapnel-induced beryllium-sensitization and associated pulmonary disease. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct; 29(2):147-50.
    View in: PubMed
    Score: 0.108
  28. Hines SE, Pacheco K, Maier LA. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease. Curr Opin Allergy Clin Immunol. 2012 Apr; 12(2):102-10.
    View in: PubMed
    Score: 0.104
  29. Ribeiro M, Fritscher LG, Al-Musaed AM, Balter MS, Hoffstein V, Mazer BD, Maier LA, Liss GM, Tarlo SM. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung. 2011 Jun; 189(3):233-41.
    View in: PubMed
    Score: 0.097
  30. Sawyer RT, Maier LA. Chronic beryllium disease: an updated model interaction between innate and acquired immunity. Biometals. 2011 Feb; 24(1):1-17.
    View in: PubMed
    Score: 0.094
  31. Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol. 2010 Oct; 43(4):458-64.
    View in: PubMed
    Score: 0.088
  32. Mroz MM, Maier LA, Strand M, Silviera L, Newman LS. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med. 2009 Oct; 52(10):762-73.
    View in: PubMed
    Score: 0.087
  33. Mack DG, Lanham AK, Palmer BE, Maier LA, Watts TH, Fontenot AP. 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease. J Immunol. 2008 Sep 15; 181(6):4381-8.
    View in: PubMed
    Score: 0.081
  34. Palmer BE, Mack DG, Martin AK, Gillespie M, Mroz MM, Maier LA, Fontenot AP. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease. J Immunol. 2008 Feb 15; 180(4):2704-12.
    View in: PubMed
    Score: 0.078
  35. Sawyer RT, Fontenot AP, Barnes TA, Parsons CE, Tooker BC, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Hagman J, Newman LS. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):191-200.
    View in: PubMed
    Score: 0.071
  36. Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15; 175(10):7029-37.
    View in: PubMed
    Score: 0.067
  37. Fontenot AP, Palmer BE, Sullivan AK, Joslin FG, Wilson CC, Maier LA, Newman LS, Kotzin BL. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest. 2005 Oct; 115(10):2886-93.
    View in: PubMed
    Score: 0.066
  38. Pott GB, Palmer BE, Sullivan AK, Silviera L, Maier LA, Newman LS, Kotzin BL, Fontenot AP. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol. 2005 May; 115(5):1036-42.
    View in: PubMed
    Score: 0.064
  39. Sawyer RT, Dobis DR, Goldstein M, Velsor L, Maier LA, Fontenot AP, Silveira L, Newman LS, Day BJ. Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic Biol Med. 2005 Apr 01; 38(7):928-37.
    View in: PubMed
    Score: 0.064
  40. Sackett HM, Maier LA, Silveira LJ, Mroz MM, Ogden LG, Murphy JR, Newman LS. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med. 2004 Sep; 46(9):953-61.
    View in: PubMed
    Score: 0.062
  41. Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Silveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004 Oct; 31(4):470-7.
    View in: PubMed
    Score: 0.061
  42. Sawyer RT, Parsons CE, Fontenot AP, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Newman LS. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):122-30.
    View in: PubMed
    Score: 0.059
  43. Kittle LA, Sawyer RT, Fadok VA, Maier LA, Newman LS. Beryllium induces apoptosis in human lung macrophages. Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun; 19(2):101-13.
    View in: PubMed
    Score: 0.053
  44. Fontenot AP, Maier LA, Canavera SJ, Hendry-Hofer TB, Boguniewicz M, Barker EA, Newman LS, Kotzin BL. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J Immunol. 2002 Apr 01; 168(7):3627-34.
    View in: PubMed
    Score: 0.052
  45. Sawyer RT, Maier LA, Kittle LA, Newman LS. Chronic beryllium disease: a model interaction between innate and acquired immunity. Int Immunopharmacol. 2002 Feb; 2(2-3):249-61.
    View in: PubMed
    Score: 0.051
  46. Lundgren RA, Maier LA, Rose CS, Balkissoon RC, Newman LS. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest. 2001 Nov; 120(5):1702-8.
    View in: PubMed
    Score: 0.051
  47. Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg. 2001 May; 16(5):579-92.
    View in: PubMed
    Score: 0.049
  48. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med. 2001 Mar; 43(3):231-7.
    View in: PubMed
    Score: 0.048
  49. Maier LA, Sawyer RT, Tinkle SS, Kittle LA, Barker EA, Balkissoon R, Rose C, Newman LS. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis. Eur Respir J. 2001 Mar; 17(3):403-15.
    View in: PubMed
    Score: 0.048
  50. Sawyer RT, Fadok VA, Kittle LA, Maier LA, Newman LS. Beryllium-stimulated apoptosis in macrophage cell lines. Toxicology. 2000 Aug 21; 149(2-3):129-42.
    View in: PubMed
    Score: 0.047
  51. Farris GM, Newman LS, Frome EL, Shou Y, Barker E, Habbersett RC, Maier L, Smith HN, Marrone BL. Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT. Toxicology. 2000 Feb 21; 143(2):125-40.
    View in: PubMed
    Score: 0.045
  52. Martyny JW, Hoover MD, Mroz MM, Ellis K, Maier LA, Sheff KL, Newman LS. Aerosols generated during beryllium machining. J Occup Environ Med. 2000 Jan; 42(1):8-18.
    View in: PubMed
    Score: 0.045
  53. Atif SM, Mack DG, McKee AS, Rangel-Moreno J, Martin AK, Getahun A, Maier LA, Cambier JC, Tuder R, Fontenot AP. Protective role of B cells in sterile particulate-induced lung injury. JCI Insight. 2019 05 16; 5.
    View in: PubMed
    Score: 0.043
  54. Liu B, Maier LA, Hamzeh N, MacPhail K, Mroz MM, Liu H, Li L. Polymorphism of FCGR3A gene in chronic beryllium disease. Genes Immun. 2019 07; 20(6):493-499.
    View in: PubMed
    Score: 0.041
  55. Tooker BC, Bowler RP, Orcutt JM, Maier LA, Christensen HM, Newman LS. SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med. 2011 Oct; 68(10):759-64.
    View in: PubMed
    Score: 0.024
  56. Mack DG, Lanham AM, Palmer BE, Maier LA, Fontenot AP. CD27 expression on CD4+ T cells differentiates effector from regulatory T cell subsets in the lung. J Immunol. 2009 Jun 01; 182(11):7317-24.
    View in: PubMed
    Score: 0.021
  57. Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol. 2007 Sep 15; 179(6):4255-62.
    View in: PubMed
    Score: 0.019
  58. Palmer BE, Mack DG, Martin AK, Maier LA, Fontenot AP. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease. J Allergy Clin Immunol. 2007 Jul; 120(1):184-91.
    View in: PubMed
    Score: 0.018
  59. Newman LS, Maier LA, Martyny JW, Mroz MM, VanDyke M, Sackett HM. Beryllium workers' health risks. J Occup Environ Hyg. 2005 Jun; 2(6):D48-50.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)